Market Overview:
The global 3D bioprinting market is expected to grow at a CAGR of over 20% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for organ transplants, rising prevalence of chronic diseases, and technological advancements in 3D printing technology. Based on type, the global 3D bioprinting market is segmented into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting, and microextrusion 3D bioprinting. In terms of application, the market is segmented into clinical applications such as tissue engineering and regenerative medicine; research applications such as drug discovery and medical research; and cell culture applications. Geographically, the global 3D printing market is segmented into North America (U.S., Canada), Latin America (Brazil), Europe (Germany France Italy Spain U.K.), Asia Pacific (Japan China India Australia South Korea) MEA (South Africa Saudi Arabia UAE).
Product Definition:
3D bioprinting is the process of creating three-dimensional structures using living cells. 3D printing technology allows for the fabrication of tissue-like structures that can be used for a variety of applications, including drug testing, regenerative medicine, and organ transplantation.
Magnetic 3D Bioprinting:
Magnetic 3D bioprinting is a technology that uses magnetic fields to guide cells and tissues in the body for printing them on a suitable material. It's major advantage is that it can create living tissue with the help of inkjet-like technology. The process involves high precision magnetic levitation, jetting of biological materials along with oxygen, and temperature control systems.
Laser-assisted Bioprinting:
Laser-assisted bioprinting is a technique that utilizes laser for cell printing. It helps in building 3D living tissues and organs by using a digital file that contains the information about the structure of interest, which is then converted into living tissue or organ structures on demand.
Application Insights:
The clinical applications segment accounted for the largest market share in 2017 and is anticipated to maintain its dominance over the forecast period. This can be attributed to a rise in demand for customized tissue engineering scaffolds, which are used for treating disorders such as heart diseases, lung disorders, liver diseases and blood vessel conditions.
Moreover, growing adoption of 3D bioprinting techniques in regenerative medicine is expected to drive the market over the forecast period. The technique offers several advantages including precise control of cell-based structures; rapid generation of large quantities of tissue models; and ease in modifying designs & functions as per requirements. Several companies have started their research activities with an aim toward regenerative medicine application development through this technology platform. For instance, researchers at The University Of Texas Medical Branch At Galveston have developed a method that uses 3D bioprinting technology for developing patient-specific stem cells therapy tissues and organs [28].
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of industry players, high adoption rate for technologically advanced products and solutions, and increasing investments in R&D activities. The region is expected to maintain its dominance throughout the forecast period owing to continuous innovations coupled with growing research initiatives undertaken by major companies operating in this space.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as rising healthcare expenditure, improving infrastructure facilities for manufacturing & testing 3D bioprinted tissue constructs and an increase in government funding for biomedical research projects that include use of 3D bioprinting technology platforms. In addition, favorable regulatory policies framed by governments across various countries are also expected favorably impact regional growth over next eight years.
Growth Factors:
- Increasing demand for organ transplants: The increasing demand for organ transplants is one of the key growth drivers for the 3D bioprinting market. According to a study by the United Network for Organ Sharing (UNOS), as of May 2017, there were more than 114,000 people in the U.S. awaiting an organ transplant and 21 people die every day due to lack of available organs. This growing need is expected to drive the adoption of 3D bioprinting technology as it can help in printing customized organs on-demand using patient-specific cells.
- Advances in 3D printing technology: The advances in 3D printing technology are another key factor driving the growth of the 3D bioprinting market. With each passing year, new printers are being launched with better features and capabilities, which is helping to expand its applications across various industries including healthcare and pharmaceuticals sectors . This is also aiding in lowering its costs, making it more affordable for end users such as hospitals and research institutes .
Scope Of The Report
Report Attributes
Report Details
Report Title
3D Bioprinting Market Research Report
By Type
Magnetic 3D Bioprinting, Laser-assisted Bioprinting, Inkjet 3D Bioprinting, Microextrusion 3D Bioprinting
By Application
Clinical Applications, Research Applications, Drug and Medical Research, Regenerative Medicine, 3D Cell Culture
By Companies
Organovo Holdings Inc, EnvisionTEC GmbH, Nano3D Biosciences, Inc, Cyfuse Biomedical K.K, Advanced Solutions, Inc, Aspect Biosystems Ltd, 3Dynamic Systems Ltd, regenHU, Cellink, Regenovo Biotechnology Co., Ltd, Poietis, GeSiM, Exone, Stratasys, Advanced BioMatrix, Ricoh Company Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global 3D Bioprinting Market Report Segments:
The global 3D Bioprinting market is segmented on the basis of:
Types
Magnetic 3D Bioprinting, Laser-assisted Bioprinting, Inkjet 3D Bioprinting, Microextrusion 3D Bioprinting
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Applications, Research Applications, Drug and Medical Research, Regenerative Medicine, 3D Cell Culture
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Organovo Holdings Inc
- EnvisionTEC GmbH
- Nano3D Biosciences, Inc
- Cyfuse Biomedical K.K
- Advanced Solutions, Inc
- Aspect Biosystems Ltd
- 3Dynamic Systems Ltd
- regenHU
- Cellink
- Regenovo Biotechnology Co., Ltd
- Poietis
- GeSiM
- Exone
- Stratasys
- Advanced BioMatrix
- Ricoh Company Ltd
Highlights of The 3D Bioprinting Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Magnetic 3D Bioprinting
- Laser-assisted Bioprinting
- Inkjet 3D Bioprinting
- Microextrusion 3D Bioprinting
- By Application:
- Clinical Applications
- Research Applications
- Drug and Medical Research
- Regenerative Medicine
- 3D Cell Culture
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 3D Bioprinting Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
3D Bioprinting is a process of creating three-dimensional objects from biological materials by using digital models to create the object's shape. The 3D printer deposits layers of biocompatible material, one on top of the other, to build up an object.
Some of the major companies in the 3d bioprinting market are Organovo Holdings Inc, EnvisionTEC GmbH, Nano3D Biosciences, Inc, Cyfuse Biomedical K.K, Advanced Solutions, Inc, Aspect Biosystems Ltd, 3Dynamic Systems Ltd, regenHU, Cellink, Regenovo Biotechnology Co., Ltd, Poietis, GeSiM, Exone, Stratasys, Advanced BioMatrix, Ricoh Company Ltd.
The 3d bioprinting market is expected to register a CAGR of 20%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 3D Bioprinting Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 3D Bioprinting Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 3D Bioprinting Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the 3D Bioprinting Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global 3D Bioprinting Market Size & Forecast, 2018-2028
4.5.1 3D Bioprinting Market Size and Y-o-Y Growth
4.5.2 3D Bioprinting Market Absolute $ Opportunity
Chapter 5 Global 3D Bioprinting Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 3D Bioprinting Market Size Forecast by Type
5.2.1 Magnetic 3D Bioprinting
5.2.2 Laser-assisted Bioprinting
5.2.3 Inkjet 3D Bioprinting
5.2.4 Microextrusion 3D Bioprinting
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global 3D Bioprinting Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 3D Bioprinting Market Size Forecast by Applications
6.2.1 Clinical Applications
6.2.2 Research Applications
6.2.3 Drug and Medical Research
6.2.4 Regenerative Medicine
6.2.5 3D Cell Culture
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global 3D Bioprinting Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 3D Bioprinting Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America 3D Bioprinting Analysis and Forecast
9.1 Introduction
9.2 North America 3D Bioprinting Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America 3D Bioprinting Market Size Forecast by Type
9.6.1 Magnetic 3D Bioprinting
9.6.2 Laser-assisted Bioprinting
9.6.3 Inkjet 3D Bioprinting
9.6.4 Microextrusion 3D Bioprinting
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America 3D Bioprinting Market Size Forecast by Applications
9.10.1 Clinical Applications
9.10.2 Research Applications
9.10.3 Drug and Medical Research
9.10.4 Regenerative Medicine
9.10.5 3D Cell Culture
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe 3D Bioprinting Analysis and Forecast
10.1 Introduction
10.2 Europe 3D Bioprinting Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe 3D Bioprinting Market Size Forecast by Type
10.6.1 Magnetic 3D Bioprinting
10.6.2 Laser-assisted Bioprinting
10.6.3 Inkjet 3D Bioprinting
10.6.4 Microextrusion 3D Bioprinting
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe 3D Bioprinting Market Size Forecast by Applications
10.10.1 Clinical Applications
10.10.2 Research Applications
10.10.3 Drug and Medical Research
10.10.4 Regenerative Medicine
10.10.5 3D Cell Culture
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific 3D Bioprinting Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific 3D Bioprinting Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific 3D Bioprinting Market Size Forecast by Type
11.6.1 Magnetic 3D Bioprinting
11.6.2 Laser-assisted Bioprinting
11.6.3 Inkjet 3D Bioprinting
11.6.4 Microextrusion 3D Bioprinting
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific 3D Bioprinting Market Size Forecast by Applications
11.10.1 Clinical Applications
11.10.2 Research Applications
11.10.3 Drug and Medical Research
11.10.4 Regenerative Medicine
11.10.5 3D Cell Culture
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America 3D Bioprinting Analysis and Forecast
12.1 Introduction
12.2 Latin America 3D Bioprinting Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America 3D Bioprinting Market Size Forecast by Type
12.6.1 Magnetic 3D Bioprinting
12.6.2 Laser-assisted Bioprinting
12.6.3 Inkjet 3D Bioprinting
12.6.4 Microextrusion 3D Bioprinting
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America 3D Bioprinting Market Size Forecast by Applications
12.10.1 Clinical Applications
12.10.2 Research Applications
12.10.3 Drug and Medical Research
12.10.4 Regenerative Medicine
12.10.5 3D Cell Culture
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) 3D Bioprinting Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) 3D Bioprinting Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) 3D Bioprinting Market Size Forecast by Type
13.6.1 Magnetic 3D Bioprinting
13.6.2 Laser-assisted Bioprinting
13.6.3 Inkjet 3D Bioprinting
13.6.4 Microextrusion 3D Bioprinting
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) 3D Bioprinting Market Size Forecast by Applications
13.10.1 Clinical Applications
13.10.2 Research Applications
13.10.3 Drug and Medical Research
13.10.4 Regenerative Medicine
13.10.5 3D Cell Culture
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 3D Bioprinting Market: Competitive Dashboard
14.2 Global 3D Bioprinting Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Organovo Holdings Inc
14.3.2 EnvisionTEC GmbH
14.3.3 Nano3D Biosciences, Inc
14.3.4 Cyfuse Biomedical K.K
14.3.5 Advanced Solutions, Inc
14.3.6 Aspect Biosystems Ltd
14.3.7 3Dynamic Systems Ltd
14.3.8 regenHU
14.3.9 Cellink
14.3.10 Regenovo Biotechnology Co., Ltd
14.3.11 Poietis
14.3.12 GeSiM
14.3.13 Exone
14.3.14 Stratasys
14.3.15 Advanced BioMatrix
14.3.16 Ricoh Company Ltd
